TUDOR SURGERY — All Prescriptions & Medications — Page 2
Practice Code: N81090 | NANTWICH, CW5 5NX
Showing results 51-100 of 427
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 361 | 163.7K | £1.9K | +36.8% ▲ | |
| Escitalopram | 357 | 11.3K | £805 | +25.4% ▲ |
| Amoxicillin | 340 | 14.4K | £413 | -63.5% ▼ |
| Glucose blood testing reagents | 339 | 30.0K | £4.0K | -57.0% ▼ |
| Hydroxocobalamin | 338 | 423 | £892 | -29.8% ▼ |
| Rosuvastatin calcium | 337 | 13.0K | £421 | -62.5% ▼ |
| Ibuprofen | 330 | 37.1K | £1.1K | -35.1% ▼ |
| 330 | 179.9K | £1.4K | -66.5% ▼ | |
| Nefopam hydrochloride | 325 | 36.3K | £1.6K | +187.3% ▲ |
| 325 | 728 | £24.5K | -40.4% ▼ | |
| Budesonide | 324 | 9,789 | £8.0K | -40.2% ▼ |
| Duloxetine hydrochloride | 324 | 10.4K | £725 | -49.0% ▼ |
| Prednisolone | 316 | 18.1K | £395 | -60.5% ▼ |
| Pravastatin sodium | 310 | 11.2K | £559 | -4.5% ▼ |
| Spironolactone | 306 | 10.3K | £792 | -43.2% ▼ |
| Fexofenadine hydrochloride | 301 | 12.1K | £513 | -64.6% ▼ |
| Ferrous fumarate | 298 | 14.8K | £555 | -58.9% ▼ |
| Perindopril erbumine | 296 | 11.6K | £1.1K | -44.2% ▼ |
| Ferrous sulfate | 296 | 11.8K | £388 | -42.4% ▼ |
| Latanoprost | 294 | 2,278 | £938 | -39.4% ▼ |
| Sitagliptin | 292 | 10.3K | £762 | -25.1% ▼ |
| Digoxin | 291 | 10.1K | £731 | -23.1% ▼ |
| Codeine phosphate | 291 | 21.0K | £701 | -59.5% ▼ |
| Warfarin sodium | 281 | 10.5K | £354 | -40.4% ▼ |
| Bendroflumethiazide | 280 | 11.0K | £175 | -63.8% ▼ |
| Thiamine hydrochloride | 278 | 15.8K | £423 | -47.3% ▼ |
| Docusate sodium | 275 | 30.8K | £2.0K | -25.8% ▼ |
| Gabapentin | 275 | 29.3K | £1.5K | -72.5% ▼ |
| 273 | 4,982 | £2.2K | -58.9% ▼ | |
| Empagliflozin | 264 | 9,219 | £11.4K | -57.8% ▼ |
| Flucloxacillin sodium | 262 | 10.4K | £583 | -41.7% ▼ |
| Solifenacin | 253 | 9,545 | £353 | -47.0% ▼ |
| Other emollient preparations | 252 | 145.0K | £1.9K | -58.0% ▼ |
| Atenolol | 248 | 11.9K | £259 | -58.9% ▼ |
| Lercanidipine hydrochloride | 248 | 9,238 | £1.1K | -59.9% ▼ |
| Cyanocobalamin | 244 | 11.0K | £1.2K | -30.9% ▼ |
| Sacubitril/valsartan | 240 | 17.1K | £27.9K | +0.2% vs avg |
| Mirabegron | 232 | 7,915 | £7.3K | -42.2% ▼ |
| Nitrofurantoin | 231 | 2,078 | £1.3K | -51.6% ▼ |
| Estradiol with progestogen | 224 | 16.3K | £9.6K | -34.3% ▼ |
| Bumetanide | 214 | 9,552 | £952 | -21.4% ▼ |
| Insulin aspart | 213 | 1,637 | £9.2K | -44.1% ▼ |
| Ezetimibe | 212 | 7,079 | £1.2K | -70.2% ▼ |
| Insulin glargine | 211 | 1,171 | £8.0K | -25.7% ▼ |
| Umeclidinium bromide/vilanterol | 210 | 263 | £8.1K | +7.7% ▲ |
| Sildenafil (Erectile Dysfunction) | 206 | 1,180 | £165 | -59.1% ▼ |
| Lamotrigine | 205 | 12.7K | £1.9K | -65.3% ▼ |
| Carbocisteine | 204 | 41.6K | £1.7K | -61.8% ▼ |
| Hydrocortisone | 203 | 6,035 | £1.1K | -54.7% ▼ |
| Memantine hydrochloride | 202 | 7,909 | £2.3K | -38.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.